School of Optometry 眼科視光學院
Home About Us What's New Subscribe eNewsletter Contact Us My School 繁體 简体 Text Only Print
About us
Message from Interim Head of School
Vision & Mission
Our People
Academic Staff
Affiliate Faculty Members
Honorary & Adjunct Professor
Visiting Staff & Academic Visitors
Optometry Clinic Staff
Research Staff
Research Students
Our Research
About us > Our People > Research Students > Ms Li PAN
Our People
Mr Samuel ABOKYI | Ms Jingfang Jennifer BIAN | Mr Shashi Kant CHAUDHARY | Mr Ka Wai Jimmy CHEUNG | Ms Sin Wan Peggy CHEUNG | Mr Man Pan Bruce CHIN | Mr Kai Yip CHOI | Mr Byung Soo Jeremy KANG | Ms Yamunadevi LAKSHMANAN | Ms Hang I Christie LAM | Mr Ki Kit LAU | Ms Hoi Lam LI | Ms Zhechuang Serena LI | Ms Sonal Aswin VYAS | Mr Kin Ken WAN | Mr Hu XIAO | Ms Ning Jenny ZHANG | Ms Biyue GUO | Ms Li PAN | Ms Qi TAN | Mr Mezbah UDDIN | Ms Meng CHENG | Mr Bing Yuan KONG | Ms Rong LI | Ms Yuanyuan LIANG | Ms Anqi LYU | Mr Ying Hon SZE | Ms Qin WANG | Ms Seema BANERJEE | Ms Hangyu ZHANG | Ms Wei YANG

Ms Li PAN

Ms Li PAN
MPhil

Title of project:
Traditional Chinese Medicines and Neuroprotection
 
Synopsis:
The project aims to determine whether these TCMs can potentially be used as anti-glaucoma agents, and we shall investigate the effects of these TCMs on 1) IOP; and 2) neuroprotective effects; 3) mechanism of neuroprotection. The results of this project will enable us to understand the functional importance of baicalein as anti-glaucoma drugs. We hope that TCMs with fewer side effects can be developed for clinical use. 

Glaucoma is a progressive optic neuropathy characterized by a specific pattern of optic nerve head and visual field damage. Because of the absence of noticeable symptoms, glaucoma often leads to substantial visual loss before diagnosis. Until now, glaucoma remains incurable although its progression can be retarded by lowering the IOP by anti-glaucoma drugs. Neuroprotection has been proposed to facilitate in delaying the disease progression, but has not yet been successfully developed as an alternative treatment option. Because of the issues regarding drug resistance and patient compliance, novel agents with more potent and long-lasting actions are required. Baicalein (5,6,7-trihydroxyflavone) has a broad spectrum of bioactivity and has been shown that baicalein can be used in the treatment of neuropathies and cognitive impairment.